We treated 18 post-menopausal women with advanced breast cancer with medroxyprogesterone-acetate 1000 mg p.o. daily. The study of granulocyte-macrophage colony forming units (GM-CFU) performed monthly, and peripheral white blood cell count showed an increase of granulocytes not statistically significant and a progressive decrease of GM-CFU that could protect marrow from chemotherapeutic agents or interfere with the myelosuppression of cytotoxic drugs.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
advanced breast
8
breast cancer
8
decrease granulocyte-macrophage
4
granulocyte-macrophage colony-forming
4
colony-forming units
4
units high
4
high dose
4
dose medroxyprogesterone
4
medroxyprogesterone acetate
4
acetate treatment
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!